1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Scabies Global Clinical Trials Review, H1, 2016

Scabies Global Clinical Trials Review, H1, 2016

  • May 2016
  • -
  • GlobalData
  • -
  • 43 pages

Scabies Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Scabies Global Clinical Trials Review, H1, 2016" provides an overview of Scabies clinical trials scenario. This report provides top line data relating to the clinical trials on Scabies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Scabies Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Scabies to Dermatology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Scabies to Dermatology Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Scabies Therapeutics Clinical Trials 24
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 40
Abbreviations 40
Definitions 40
Research Methodology 41
Secondary Research 41
About GlobalData 42
Contact Us 42
Disclaimer 42
Source 43

List of Tables
Scabies Therapeutics, Global, Clinical Trials by Region, 2016* 5
Scabies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Scabies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Scabies Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Scabies Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9
Scabies Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Scabies Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Scabies Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12
Proportion of Scabies to Dermatology Clinical Trials, G7 Countries (%), 2016* 13
Scabies Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Scabies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Scabies to Dermatology Clinical Trials, E7 Countries (%), 2016* 16
Scabies Therapeutics, Global, Clinical Trials by Phase, 2016* 17
Scabies Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18
Scabies Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Scabies Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Scabies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Scabies Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22
Scabies Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Scabies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Scabies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26

List of Figures
Scabies Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Scabies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Scabies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Scabies Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
Scabies Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9
Scabies Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 11
Proportion of Scabies to Dermatology Clinical Trials, G7 Countries (%), 2016* 13
Scabies Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Scabies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Scabies to Dermatology Clinical Trials, E7 Countries (%), 2016* 16
Scabies Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17
Scabies Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18
Scabies Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Scabies Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Scabies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Scabies Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22
Scabies Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Scabies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Scabies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26
GlobalData Methodology 41

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.